Publications 2022

Regulatory T cells as metabolic sensors.

de Candia P, Procaccini C, Russo C, Lepore MT, Matarese G.
Immunity. 2022 Nov 8;55(11):1981-1992. doi: 10.1016/j.immuni.2022.10.006.

Metabolism, clinical and experimental: seventy years young and growing.

Polyzos SA, Hill MA, Fuleihan GE, Gnudi L, Kim YB, Larson S, Masuzaki H, Matarese G, Sanoudou D, Tena-Sempere M, Mantzoros CS.
Metabolism. 2022 Oct 13:155333. doi: 10.1016/j.metabol.2022.155333.

A rapid and inexpensive genotyping method using dried blood spots for mutational analysis in a mutant mouse model: an update.

Romano A, Zuchegna C, Zannini G, Messina S, Fusco C, Pezone A, Grillo R, de Candia P, Matarese G, Porcellini A.
Mol Biol Rep. 2022 Jun 22. doi: 10.1007/s11033-022-07649-x.

High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease.

Bruzzaniti S, Piemonte E, Mozzillo E, Bruzzese D, Lepore MT, Carbone F, de Candia P, Strollo R, Porcellini A, Marigliano M, Maffeis C, Bifulco M, Ludvigsson J, Franzese A, Matarese G, Galgani M.
Diabetologia. 2022 May 25. doi: 10.1007/s00125-022-05724-3.

Gluten consumption and inflammation affect the development of celiac disease in at-risk children.

Auricchio Renata, Calabrese Ilaria, Galatola Martina, Cielo Donatella, Carbone Fortunata, Mancuso Marianna, Matarese Giuseppe, Troncone Riccardo, Auricchio Salvatore & Greco Luigi
Sci Rep. 2022 Mar 30;12(1):5396. doi: 10.1038/s41598-022-09232-7.

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis.

Azzolini F, Gilio L, Pavone L, Iezzi E, Dolcetti E, Bruno A, Buttari F, Musella A, Mandolesi G, Guadalupi L, Furlan R, Finardi A, Micillo T, Carbone F, Matarese G, Centonze D, Stampanoni Bassi M.
Biomolecules. 2022 Jan 27;12(2):222. doi: 10.3390/biom12020222.

The folate way to T cell fate.

de Candia P, Matarese G.
Immunity. 2022 Jan 11;55(1):1-3. doi: 10.1016/j.immuni.2021.12.009.

PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism: Drp1-dependent mechanism.

Simula L, Antonucci Y, Scarpelli G, Cancila V, Colamatteo A, Manni S, De Angelis B, Quintarelli C, Procaccini C, Matarese G, Tripodo C, Campello S.
Mol Oncol. 2022 Jan;16(1):188-205. doi: 10.1002/1878-0261.13103.

MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.

De Vito F, Musella A, Fresegna D, Rizzo FR, Gentile A, Bassi MS, Gilio L, Buttari F, Procaccini C, Colamatteo A, ......... Fusco C, Bruzzaniti S, Hornstein E, Uccelli A, Salvetti M, Matarese G, Centonze D, Mandolesi G.
Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12765. doi: 10.1111/nan.12765.